Gou YP, Huang Y, Chen L, Zheng W, Zheng YH. Analysis and monitoring of drug therapy in a patient with peptic ulcer complicated by infection: A case report. World J Clin Cases 2024; 12(8): 1530-1535 [PMID: 38576803 DOI: 10.12998/wjcc.v12.i8.1530]
Corresponding Author of This Article
Yun-Hua Zheng, PharmD, Assistant Lecturer, Pharmacist, Research Scientist, Senior Statistician, Quality Evaluation and Medical Record Management, The Affiliated Hospital of Southwest Jiaotong University & The Third People’s Hospital of Chengdu, No. 82 Qinglong Street, Qingyang District, Chengdu 610000, Sichuan Province, China. 13125549713@163.com
Research Domain of This Article
Pharmacology & Pharmacy
Article-Type of This Article
Case Report
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Clin Cases. Mar 16, 2024; 12(8): 1530-1535 Published online Mar 16, 2024. doi: 10.12998/wjcc.v12.i8.1530
Analysis and monitoring of drug therapy in a patient with peptic ulcer complicated by infection: A case report
Yan-Ping Gou, Yue Huang, Li Chen, Wei Zheng, Yun-Hua Zheng
Yan-Ping Gou, The Second People’s Hospital of Meishan City & Renshou County People’s Hospital, Meishan 620500, Sichuan Province, China
Yue Huang, Li Chen, Yun-Hua Zheng, Quality Evaluation and Medical Record Management, The Affiliated Hospital of Southwest Jiaotong University & The Third People's Hospital of Chengdu, Chengdu 610000, Sichuan Province, China
Wei Zheng, Patriotic Health Campaign, Qionglai City Health Bureau, Chengdu 610000, Sichuan Province, China
Author contributions: Gou YP was the patient’s pharmacist; Huang Y reviewed the literature and contributed to manuscript drafting; Zheng YH, Chen L and Zheng W collected the information from the patient; Zheng YH was responsible for revision of the manuscript; Gou YP and Zheng YH reviewed and edited the paper. All authors have read and approved the final version of the manuscript.
Informed consent statement: The informed consent was obtained from the patient for the entire treatment process and publication of this paper.
Conflict-of-interest statement: The authors declare no conflict of interest.
CARE Checklist (2016) statement: The authors have read the CARE Checklist (2016), and the manuscript was prepared and revised according to the CARE Checklist (2016).
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Yun-Hua Zheng, PharmD, Assistant Lecturer, Pharmacist, Research Scientist, Senior Statistician, Quality Evaluation and Medical Record Management, The Affiliated Hospital of Southwest Jiaotong University & The Third People’s Hospital of Chengdu, No. 82 Qinglong Street, Qingyang District, Chengdu 610000, Sichuan Province, China. 13125549713@163.com
Received: December 21, 2023 Peer-review started: December 21, 2023 First decision: January 10, 2024 Revised: February 7, 2024 Accepted: February 21, 2024 Article in press: February 21, 2024 Published online: March 16, 2024
Abstract
BACKGROUND
The role of primary-level medical pharmacists in medical institutions in China is limited; therefore, it is necessary to explore the role of pharmacists in the process of drug treatment.
CASE SUMMARY
A Chinese pharmacist participated in the complete treatment of a patient with a duodenal ulcer. The rationale for drug treatment was evaluated, and adjustments were made to the antacid and anti-infective regimen, as well as the dose and frequency of administration. Body temperature, routine blood examination, and adverse drug reactions were strictly monitored. During treatment, the pharmacist recommended anti-infective therapy with ampicillin–sulbactam, which effectively controlled the infection. Additionally, the pharmacist suggested changing famotidine to lansoprazole for acid suppression and gastroprotective treatment, combined with Chinese patent medicine such as Kangfuxin Liquid. This is the first case report of a pharmacist in primary-level medical institutions adjusting drug use for patients with duodenal ulcer and pulmonary infection.
CONCLUSION
A pharmacist participated in the treatment process, provided individualized medication adjustment, and achieved good clinical results.
Core Tip: Duodenal ulcer is a common digestive disease in clinical practice. The main treatment methods are to heal the ulcer, prevent recurrence and avoid complications. For the first time, we report a case of pharmacist in a medical institution participating in the treatment process of a patient with duodenal ulcer and pulmonary infection. It is worth noting that the drug combined with Kangfuxin Liquid had a good effect, which reminds us that individualized treatment is necessary and combination with Kangfuxin Liquid is a valuable research direction.
